Uncategorized
-
Medium spiny neurons and “sticking” to bad habits
By Alexandra Fuller By the time March rolls around, New Year’s resolutions to ditch the expensive lattes and spend less time (and money) shopping online are often far behind us. Activity within the nucleus accumbens, a region of the brain implicated in motivation and addiction, may be at play. Read MoreDec. 15, 2020
-
Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease
by Marissa Shapiro Nov. 17, 2020, 12:00 PM Ancora Innovation LLC, a Deerfield Management company that supports Vanderbilt University’s innovative life science research, will fund further research into therapeutics for Charcot-Marie-Tooth disease, an inherited condition that damages peripheral nerves. This is the third Vanderbilt project… Read MoreNov. 18, 2020
-
A visiting scholar’s experience with the lockdown in Nashville
By Naotoshi Nakamura Dr. Nakamura, a Specially Appointed Associate Professor at the Center for Mathematical Modeling and Data Science, Osaka University, was a visiting scholar in the Vito Quaranta lab and has since become a long-distance participant in discussions and lab meetings. Nakamura has also been appointed as… Read MoreOct. 7, 2020
-
Understanding sex-based behaviors may improve psychiatric treatments
By Sara Eaton There are biological differences in how male and female mice respond to different cues in their environment. Deciphering those differences can help researchers develop drugs that work equally well in both human sexes. New research from the labs of Erin Calipari and Cody Siciliano, both… Read MoreAug. 5, 2020
-
Cellular stress regulates β-cell dysfunction in type 2 diabetes
By Heather Caslin Approximately 30 million Americans have type 2 diabetes. The majority are over 45 years old. © Vitalii Vodolazskyi, stock.adobe.com Within the pancreas, β-cells produce insulin that delivers energy to tissues through glucose. People with type 2 diabetes have smaller, less functional β-cells; however, the mechanisms that drive… Read MoreJun. 26, 2020
-
Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders
by Ryan Underwood Jun. 16, 2020, 4:23 PM Vanderbilt University’s Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc., which will seek to develop and commercialize treatments for central… Read MoreJun. 18, 2020
-
Biomedical umbrella programs recruit the cream of the crop
By Beth Bowman and Lorena Infante Lara Recruiting for Fall 2020 admission in the Interdisciplinary Graduate Program in Biomedical Sciences and the Quantitative and Chemical Biology program wrapped up earlier this month with a banner year. Both umbrella programs saw an increase in the number and… Read MoreApr. 29, 2020
-
-
Clinical investigation society lauds Vanderbilt scientists
Mar. 12, 2020, 8:45 AM by Bill Snyder Five faculty members of Vanderbilt University School of Medicine are among 80 physician-scientists who will be inducted this year into the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. Read MoreMar. 18, 2020
-